Miruvor
Sign up
ME/CFS Moderate → somewhat better

ME/CFS somewhat better on a clinical-trial medication, not enough to return to work

Condition
ME/CFS
At worst
Moderate (mostly housebound)
Ill before improving or writing
Not stated
Last post
Oct 2026
In their words
  • Condition: ME/CFSDitto for GLP-1, which is in clinical trials in Berlin. Hopefully it will be approved for mecfs soon. In context ↗
  • At worst: Moderateit’s improved my symptoms a lot, not enough to return to work but significantly enough that my quality of life improved In context ↗
  • Now: Somewhat betterit’s improved my symptoms a lot, not enough to return to work but significantly enough that my quality of life improved In context ↗
Read from 2 of their posts and comments; links to the 2 this page draws on

Request to remove this story

Summary

An ME/CFS patient said a medication in clinical trials improved their symptoms a lot and their quality of life, though not enough to return to work; they suggested checking out Dr Carmen Scheibenbogen. They also referenced GLP-1 as being in clinical trials in Berlin. No onset, duration, or specific symptoms were described.

Ask Miruvor AI

Asking aboutOak 75702’s story

What they tried

Also tried

a medication that is in clinical trials· Helped a lot
Their words about each treatment
  • a medication that is in clinical trials · Helped a lotmy doctor put me on a medication that is in clinical trials (check out Dr Carmen Scheibenbogen) and it’s improved my symptoms a lot In context ↗

Ask Miruvor AI

Asking aboutOak 75702’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime